Insiders Genocea Biosciences, Inc.

Equities

GNCAQ

US3724274010

Delayed OTC Markets Other stock markets 16:32:30 30/04/2024 BST			5-day change	1st Jan Change
0.000001 ^USD	-.--%		-.--%	-99.00%

2023	Genocea Biosciences, Inc. Went Out of Business	CI
2023	Liquidation Plan Approved for Genocea Biosciences, Inc.	CI

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Genocea Biosciences, Inc. Announces Resignation of Ali Behbahani from Board of Director	01/06/22	CI
John Lunger Joins Genocea Biosciences' Board of Directors	07/03/22	CI
Genocea Biosciences, Inc. Appoints Jennifer Herron to Its Board of Directors	13/09/21	CI
Genocea Biosciences Announces Board Changes	14/04/21	CI
Genocea Biosciences, Inc. Appoints Raymond D. Stapleton, Jr. as Executive Vice President of Pharmaceutical Sciences and Manufacturing	11/02/21	CI
Genocea Biosciences, Inc. Announces Resignation of Howard Mayer from the Board of Directors	05/08/20	CI
Genocea Biosciences, Inc. Appoints Gisela Schwab to its Board of Directors, Effective February 14, 2020	13/02/20	CI
Genocea Biosciences, Inc. Appoints Diantha Duvall as Chief Financial Officer, Effective from March 5, 2019	28/02/19	CI
Genocea Biosciences, Inc. Appoints Girish Aakalu as Chief Business Officer	10/12/18	CI
Genocea Biosciences, Inc. Announces Executive Appointments	01/10/18	CI
Genocea Biosciences, Inc. Appoints Michael Alfieri as Principal Financial Officer and Principle Accounting Officer	25/06/18	CI
Genocea Appoints Narinder Singh as SVP Pharmaceutical Sciences & Manufacturing	12/03/18	CI
Genocea Biosciences, Inc. Announces Resignation of Jonathan Poole as Chief Financial Officer, Effective March 23, 2018	09/03/18	CI
Genocea Biosciences, Inc. Appoints Ali Behbahani to Board of Directors, Effective February 8, 2018	12/02/18	CI
Genocea Biosciences, Inc. Announces Executive Changes	31/01/18	CI
Genocea Biosciences, Inc. Announces Board Changes	17/04/17	CI
Genocea Biosciences, Inc. Announces Board Changes	06/03/17	CI
Genocea Biosciences, Inc. Appoints Ron Cooper to its Board of Directors	09/06/16	CI
Genocea Biosciences, Inc. Appoints John E. Bishop as Senior Vice President of Pharmaceutical Sciences	23/05/16	CI
Genocea Biosciences, Inc. Appoints Michael Higgins as Directors	27/02/15	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Insiders Genocea Biosciences, Inc.

Equities

GNCAQ

US3724274010

Insiders

Filters